73.79
Precedente Chiudi:
$68.83
Aprire:
$74.18
Volume 24 ore:
3.97M
Relative Volume:
2.89
Capitalizzazione di mercato:
$5.11B
Reddito:
-
Utile/perdita netta:
$-153.72M
Rapporto P/E:
-36.90
EPS:
-2
Flusso di cassa netto:
$-103.81M
1 W Prestazione:
+17.66%
1M Prestazione:
+16.37%
6M Prestazione:
+116.70%
1 anno Prestazione:
+368.92%
Verona Pharma Plc Adr Stock (VRNA) Company Profile
Nome
Verona Pharma Plc Adr
Settore
Industria
Telefono
011-44-0-2032834200
Indirizzo
3 MORE LONDON RIVERSIDE, LONDON
Confronta VRNA con altri titoli
Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
---|---|---|---|---|---|---|
![]()
VRNA
Verona Pharma Plc Adr
|
73.32 | 5.11B | 0 | -153.72M | -103.81M | -2.00 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
505.27 | 122.76B | 11.02B | -535.60M | -978.00M | -2.20 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
566.85 | 61.38B | 14.20B | 4.41B | 3.54B | 38.28 |
![]()
ARGX
Argen X Se Adr
|
630.58 | 36.37B | 2.19B | 833.04M | -1.28B | 12.71 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
258.59 | 30.12B | 2.25B | -278.16M | -42.59M | -2.17 |
![]()
ONC
Beigene Ltd Adr
|
247.96 | 24.70B | 3.81B | -644.79M | -669.77M | -6.24 |
Verona Pharma Plc Adr Stock (VRNA) Upgrades & Downgrades
Data | Azione | Analista | Modifica della valutazione |
---|---|---|---|
2025-04-21 | Iniziato | Cantor Fitzgerald | Overweight |
2025-01-10 | Iniziato | ROTH MKM | Buy |
2024-10-03 | Iniziato | Wells Fargo | Overweight |
2023-05-22 | Ripresa | Jefferies | Buy |
2022-09-19 | Ripresa | Wedbush | Outperform |
2022-08-26 | Iniziato | Piper Sandler | Overweight |
2021-09-13 | Iniziato | H.C. Wainwright | Buy |
2020-08-25 | Iniziato | Jefferies | Buy |
2020-08-10 | Iniziato | Canaccord Genuity | Buy |
2019-04-18 | Iniziato | BTIG Research | Buy |
Mostra tutto
Verona Pharma Plc Adr Borsa (VRNA) Ultime notizie
Watch this stock’s price performance: Verona Pharma Plc ADR (NASDAQ:VRNA) - uspostnews.com
Verona Pharma Reports First Quarter 2025 Financial Results and Provides Corporate Update - GlobeNewswire Inc.
Verona Pharma Plc ADR (NASDAQ: VRNA) Could Soar To Much Higher Prices In Coming Months - Marketing Sentinel
TD Cowen starts Verona Pharma stock at Buy, sets $100 target - Investing.com
Verona Pharma Shareholders Approve All Proposals at AGM By Investing.com - Investing.com South Africa
Verona Pharma Shareholders Approve All Proposals at AGM - Investing.com
A significant driver of top-line growth: Verona Pharma Plc ADR (VRNA) - Sete News
Is Astrazeneca plc ADR (AZN) positioned for future growth? - Sete News
Verona Pharma Plc ADR [VRNA] Records 50-Day SMA of $62.73 - knoxdaily.com
Tencent Music Entertainment Group ADR [TME] Officer makes an insider purchase of 1,036,363 shares worth 14.87 million. – Knox Daily - knoxdaily.com
TAL Education Group ADR [TAL] Officer makes an insider purchase of 24,041 shares worth 0.28 million. - knoxdaily.com
Ratios Uncovered: Breaking Down Verona Pharma Plc ADR (VRNA)’s Trailing Twelve Months Metrics - DWinneX
Verona Pharma Plc ADR (VRNA) is a good investment, but the stock may be overvalued - uspostnews.com
What is the investor’s view on Marriott Vacations Worldwide Corp (VAC)? - uspostnews.com
Was Phathom Pharmaceuticals Inc (PHAT)’s session last reading good? - uspostnews.com
Zentalis Pharmaceuticals Inc (ZNTL) deserves deeper analysis - uspostnews.com
Financial Health Report: Alamos Gold Inc (AGI)’s Ratios Tell a Tale - DWinneX
Cantor Fitzgerald sets $80 target on Verona Pharma stock By Investing.com - Investing.com South Africa
Verona Pharma Plc ADR [VRNA] Rickard Kathleen A. sells 79,264 Shares for $0.66 million - knoxdaily.com
Verona Pharma Plc ADR [VRNA] Chief Medical Officer makes an insider purchase of 79,264 shares worth 0.66 million. - knoxdaily.com
Verona Pharma secures $450 million credit facility on better terms By Investing.com - Investing.com South Africa
Verona Pharma secures $450 million credit facility on better terms - Investing.com
The growth track for Cracker Barrel Old Country Store Inc (CBRL) has changed recently - SETE News
Verona Pharma Plc ADR (NASDAQ: VRNA) Up 298.80% This Year: What Is Going To Happen Next - Stocks Register
Verona Pharma’s chief medical officer sells shares worth $661,941 By Investing.com - Investing.com India
Verona Pharma’s chief medical officer sells shares worth $661,941 - Investing.com
Keeping an Eye on Gilead Sciences, Inc (GILD) After Insider Trading Activity - Knox Daily
McEwen Mining Inc (MUX) Becoming More Attractive for Investors - Knox Daily
Morgan Stanley Upgrades Solaredge Technologies Inc (SEDG) to an Equal-weight from an Underweight - Knox Daily
Verona Pharma at Leerink Global Healthcare: Eutuvera’s Promising Launch By Investing.com - Investing.com UK
Earnings call transcript: Verona Pharma Q4 2024 beats EPS & revenue forecasts By Investing.com - Investing.com South Africa
Verona Pharma stock surges as Q4 revenue soars past estimates - Investing.com India
Verona Pharma stock surges as Q4 revenue soars past estimates By Investing.com - Investing.com Canada
Earnings call transcript: Verona Pharma Q4 2024 beats EPS & revenue forecasts - Investing.com
Verona Pharma plc (NASDAQ:VRNA) Q4 2024 Earnings Call Transcript - MSN
Verona Pharma ADR earnings beat by $0.02, revenue topped estimates - Investing.com UK
A company insider recently sold 640,264 shares of Verona Pharma Plc ADR [VRNA]. Should You Sale? - Knox Daily
Verona Pharma stock soars to all-time high of $62.09 - Investing.com India
Verona Pharma stock soars to all-time high of $62.09 By Investing.com - Investing.com South Africa
Canaccord raises Verona Pharma target to $72; maintains buy By Investing.com - Investing.com South Africa
Investor’s Delight: Lithium Americas Corp (NewCo) (LAC) Closes Weak at 2.97, Down -1.98 - The Dwinnex
There is no doubt that Verona Pharma Plc ADR (VRNA) ticks all the boxes. - SETE News
Analyzing Verona Pharma Plc ADR (VRNA) After Recent Trading Activity - Knox Daily
Rumble Inc (RUM)’s Market Momentum: Closing Strong at 12.25, Down -3.92 - The Dwinnex
Market Recap Check: Lineage Cell Therapeutics Inc (LCTX)’s Negative Finish at 0.66, Up/Down -2.12 - The Dwinnex
A History of Outperforming Analyst Forecasts and Beating the Odds: OrganiGram Holdings Inc (OGI) - SETE News
Are Smart Investors Making the Right Decision? Verona Pharma Plc ADR (VRNA) - SETE News
Healthy Upside Potential: Solidion Technology Inc (STI) - SETE News
Stock Surge: XPO Inc (XPO) Closes at 131.50, Marking a 2.24 Increase/Decrease - The Dwinnex
Closing Figures Unveiled: Diageo plc ADR (DEO) Drop -0.84, Closes at 115.95 - The Dwinnex
Market Watch Highlights: Verona Pharma Plc ADR (VRNA) Ends on an Upturn Note at 59.94 - The Dwinnex
Verona Pharma Plc Adr Azioni (VRNA) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):